Furthermore, by comparing the commonalities and differences between EBV-positive and EBV-negative cell lines and the EBV-positive clinical sample, we aimed to identify the mechanism by which IL-21 promotes EBV-positive DLBCL cell proliferation. This evidence concerns the gene IL21 and diffuse large B-cell lymphoma.